The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Supporting remote monitoring in an outpatient setting
We are supporting three rheumatology departments across south east London (SEL) to trial a new service that supports patients with rheumatoid arthritis (RA) to remotely monitor their condition. The service aims to help people access the care they need, when they most need it, rather than rely on routine appointments.
RefuAid is a charity that sources and supports refugee healthcare professionals to work in the NHS.www.refuaid.org
Safer medicine administration in care homes during Covid-19
The HIN engaged with OPUS and commissioned them on a pro bono basis to adapt their existing comprehensive guidance to ensure care home staff were aware of how to safely administer medicines without using a dosette box during the pandemic.
Compass Point of Care AKI & HAP App
A registered clinical device, the Compass Point of Care AKI & HAP app is a tool providing augmented intelligence in the form of decision support algorithms to support the early intervention and prevention of acute kidney injury (AKI) and hospital-acquired pneumonia. Use of this app is proven by published clinical trials and real-world use within NHS and international healthcare systems to reduce both conditions in hospitals by up to 60%. The app delivers benefits to both COVID and non-COVID patients and is available to download for IOS and Android devices.
Gendius developed product Intellin® is an intelligent diabetes management platform that uses clinical data to predict the trajectory of an individual's diabetes and helps to mitigate progression through smart tips. Powered by sophisticated AI algorithms, Intellin® is changing the way diabetes is managed. The Intellin® App is today the fastest downloaded diabetes app in the world.
Adjutant Platform for EPRR
We work in the field of EPRR – emergency preparedness, planning, risk and resilience. Adjutant are different due to our experience and deep knowledge comes from decades of front line service responding to critical situations and incidents in the military and blue light services. Unfortunately we have witnessed personally critical deficiencies in the implementation and execution of EPRR plans and experienced how poor communication provision can cost lives. So we decided to do something about it.
Early detection of melanoma is crucial for disease prognosis and survival rate. The Primary Care Innovations Programme has partnered with Gnosco to implement and evaluate the Dermicus teledermatology Platform across all GP locations on the Isle of Wight.
Life QI's journey started when an early partnership was formed in 2015 with the South West of England Academic Health Science Network, in England with an aim to deliver an online platform that assisted frontline health and social care staff in running quality improvement (QI) projects. Levels of improvement work varied across a range of organisations with limited accessibility to the data. Staff became increasingly frustrated with using multiple, clunky software applications to record their quality improvement and patient safety work which identified a clear gap in the market for an all-in-one solution.
Pando is a communications platform for healthcare professionals, created by NHS doctors which helps NHS workers exchange patient information, make clinical decisions, manage their workload, and making collaboration easy, fast and secure. Pando saves healthcare professionals more than 40 minutes per shift and improves satisfaction at work, while saving NHS Trusts £6.9m over a 5-year term.
GripAble are developing gamified mobile technologies for therapy and assessment. Common equipment used for hand and arm therapy, such as thera-putty or stress balls, have not been successfully digitised. The company’s first product, GripAble™, is a digital handgrip that wirelessly connects to a mobile app, allowing patients to play fun therapy games. It has been designed to be highly portable and patient-personalised.
The PD Safe is designed to identify potentially fatal infection in dialysis patients. This Microbiosensor device is aimed at patients with kidney failure who are being treated using peritoneal dialysis therapy (PD) and acts as an early warning system for peritoneal infection.